Skip to main content

North America to Dominate the Robotic Surgery Consumables Market with Maximum Market Share

 

Robotic surgery consumables may be defined as those instruments and accessories which are used with computer-assisted surgical systems. The equipment help the surgeons perform safe, precise, and accurate surgical procedures. Robotic surgery consumables include instruments such as scissors, forceps, and other tools. These instruments, in most cases, are specially manufactured by surgical robotic system manufacturers.

The instruments are designed in such a manner that they are able to perform a safe and minimally invasive surgical (MIS) procedure. Certain consumables, such as graspers and forceps, can be reused. They can be re-used for more than one surgery. However, they must be replaced after a certain number of procedures have been performed, as per specifications provided by the original equipment manufacturer (OEM).

The global robotic surgery consumables market is estimated to be valued at $2,831.7 million in 2019 and is projected to register a CAGR of 11.37%. The growth in the robotic surgery consumables market is mainly attributed to a faster rate of adoption of surgical robotic systems. Surgical robotic technology has significant benefits over conventional surgery in improving the efficacy and precision of procedures.

The global robotic surgery consumables market has been segmented into seven core categories on the basis of application – urology, gynecology, general surgery, cardiology, orthopedic surgery, head, and neck surgical procedure and other surgical procedures.

The share of the general surgery application in terms of value in the robotic surgery consumables market for the year 2018 is 27.57% and is the highest contributor to the market. The general surgery is expected to account for more than 45% of the total market by application, by the end of 2030. The growth rate that the gynecology segment is expected to register is around 5.79% during the forecast period.

The global robotic surgery consumables market has been segmented into three core categories on the basis of end-use – hospitals, ambulatory surgical centers (ASCs), and others (research institutions and specialty clinics). The advancement in technology in the healthcare robotics space is expected to play a key role in propelling growth in the adoption of robotic surgery systems. The increase in patient awareness and acceptance for advanced surgical technologies coupled with increasing disposable income is expected to lead to a rise in healthcare expenditure in the coming years.

Lastly, the potential of robotic surgery consumables market with respect to different regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Rest-of-the-World (ROW), has been described in this section.

In 2018, the contribution of North America was valued to be 66.52% of the total share of the market. The region is expected to contribute 45.69% of global market value in 2030. Substantial investments made by leading companies, such as Medtronic plc, Medrobotics Corporation, and Auris Health, Inc. in the field of surgical robotics play a pivotal role in the growth of the North America robotic surgery consumables market.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...